AUSTIN, Texas , Feb. 24, 2020 /PRNewswire/ --  Luminex Corporation  (NASDAQ: LMNX) today announced that the company has submitted an application to the U.S. Food and Drug Administration (FDA) for 510(k) clearance of the VERIGENE ® II Respiratory Flex Assay, the second VERIGENE II assay to be

AUSTIN, Texas , Feb. 18, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the first quarter of 2020 of $0.09 per share of common stock payable on April 9 , 2020 to stockholders of record as of the close